HomeRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Previous close
$7.40
Day range
$7.17 - $7.44
Year range
$4.54 - $16.75
Market cap
1.71B USD
Avg Volume
5.46M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 10.89M | -20.36% |
Operating expense | 272.87M | 53.01% |
Net income | -93.00M | -61.75% |
Net profit margin | -853.88 | -103.12% |
Earnings per share | -0.42 | -40.00% |
EBITDA | -92.56M | -52.81% |
Effective tax rate | 4.19% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 391.56M | -28.79% |
Total assets | 653.70M | -6.79% |
Total liabilities | 190.26M | -11.70% |
Total equity | 463.44M | — |
Shares outstanding | 234.65M | — |
Price to book | 3.74 | — |
Return on assets | -38.97% | — |
Return on capital | -49.88% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -93.00M | -61.75% |
Cash from operations | -74.08M | -65.54% |
Cash from investing | -2.49M | 68.82% |
Cash from financing | 80.66M | -45.23% |
Net change in cash | 4.22M | -95.52% |
Free cash flow | -65.79M | -403.80% |
About
Founded
2013
Headquarters
Website
Employees
500